It is well known that aberrant mTOR signaling results in diverse diseases such as diabetes type II, neurological disorders, and cancer [3], and thus a more complete understanding of the interactions of mTOR and mEAK-7 may be important to preventing or treating these human conditions. The gene discussed is MTOR; the disease is type 2 diabetes mellitus.